However, to date, there are few reports on the HSCCC preparation of these multiple compounds from AF [7], the bioactivity-guided separation of D2R antagonists from natural resources has not been reported, and it is still a complicated and challenging task. The gene discussed is DRD2; the disease is atrial fibrillation.